Stratos Wealth Partners LTD. Has $120,000 Position in AdaptHealth Corp. (NASDAQ:AHCO)

Stratos Wealth Partners LTD. cut its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 17.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,560 shares of the company’s stock after selling 2,740 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in AdaptHealth were worth $120,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of AHCO. Louisiana State Employees Retirement System increased its position in AdaptHealth by 30.0% in the 3rd quarter. Louisiana State Employees Retirement System now owns 51,100 shares of the company’s stock worth $574,000 after purchasing an additional 11,800 shares during the last quarter. State of Alaska Department of Revenue grew its stake in shares of AdaptHealth by 31.5% in the 3rd quarter. State of Alaska Department of Revenue now owns 60,304 shares of the company’s stock valued at $677,000 after buying an additional 14,438 shares in the last quarter. Harbor Capital Advisors Inc. increased its holdings in AdaptHealth by 142.9% in the third quarter. Harbor Capital Advisors Inc. now owns 449,840 shares of the company’s stock worth $5,052,000 after buying an additional 264,610 shares during the last quarter. Amalgamated Bank raised its position in AdaptHealth by 26.7% during the third quarter. Amalgamated Bank now owns 30,916 shares of the company’s stock valued at $347,000 after acquiring an additional 6,524 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its stake in AdaptHealth by 39.7% in the third quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock valued at $6,106,000 after acquiring an additional 154,434 shares during the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently commented on AHCO. Robert W. Baird dropped their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 6th. Truist Financial cut their target price on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, November 15th. Canaccord Genuity Group decreased their price target on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Royal Bank of Canada cut their price objective on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 19th. Finally, UBS Group reduced their target price on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a report on Thursday. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $12.20.

AdaptHealth Trading Down 1.7 %

AdaptHealth stock opened at $8.78 on Friday. AdaptHealth Corp. has a 52 week low of $7.01 and a 52 week high of $11.90. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The firm has a market capitalization of $1.18 billion, a PE ratio of -5.32, a PEG ratio of 1.23 and a beta of 1.12. The business’s 50-day simple moving average is $9.95 and its 200-day simple moving average is $10.28.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.